Computer Modeling Supports Theory That Many Dementias Spread Like Prion Diseases. A new technique for analyzing brain images offers the...
Researchers have identified a new genetic mutation for amyotrophic lateral sclerosis (ALS), opening the door to future targeted therapies.
Researchers discover an abnormal protein that accumulates in the brains of patients affected with ALS and frontotemporal dementia. The findings have uncovered a potentially new therapeutic target and biomarker that would allow clinicians to confirm diagnosis of the diseases.
New research supports the idea that a malfunction of the TDP-43 protein plays a decisive role in the development of ALS and FTD.
A new study uncovers unique changes in DNA structure in genes important to neuronal function in relatives with early onset, familial Alzheimer's disease.
Researchers discover a new class of experimental drug like small molecules show promise in targeting a brain enzyme to prevent early memory loss in Alzheimer's disease.
Using neurons created from iPS cells derived from people with ALS, researchers develop a new drug which appears to halt the impact of the genetic mutations in some forms of ALS and dementia.
Researchers have identified a new toxic entity associated with genetically inherited forms of frontotemporal dementia and motor neuron disease.
Researchers discover later onset of dementia in people who speak more than one language.
A new study reports that increased neural activity boosts tau levels in the brain.
Researchers discover how a specific genetic mutation leads to neuronal damage associated with ALS and frontotemporal dementia.
Researchers report retinal degeneration could be one of the earliest signs of FTD in people who have a genetic risk for the disorder.
